[ad_1]
MD Magazine, a digital portal to provide physicians with the most valuable and up-to-date resources on specific specialties and diseases to help them provide the best possible care for patients, presents its latest group discussion on how to treat patients. peer exchange, Identification of biomarkers for the treatment of severe asthma. The video series hosts several experts who will review the biological therapies currently available to treat asthmatic patients.. The panel will also deepen in-depth discussions on the importance of identifying and using biomarkers to help clinicians make important treatment decisions.
The market for biologics for the treatment of asthma has increased dramatically over the past two decades, Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of MD Magazine. In this series of informative videos, our experts come together to provide a peer-to-peer dialogue and their authoritative ideas, opinions and views on this highly selective treatment approach. They will take a closer look at different US approved biologics and their mechanisms of action.
This peer exchange group includes four distinguished experts: Neal Jain, M.D., FAAP, FAAAAI, FACAAI, Director of Research at Arizona Allergy & Immunology Research and co-owner of Acardia Allergy & Asthma and San Tan Allergy & Asthma as moderator; Nicola A. Hanania, M.D., MS, Associate Professor of Medicine in the Department of Pulmonary Medicine and Director of the Airways Clinical Research Center of Baylor College of Medicine and Director of the Clinic of Asthma and COPD at Ben Taub Hospital; Bradley E. Chipps, M.D., Certified Pediatric Respirologist, Allergy Practitioner in the Sacramento Area and Past President of the American College of Allergy, Asthma & Immunology; and Aidan A. Long, M.D., Associate Professor of Medicine at Mbadachusetts General Hospital.
The first segment of this series of peer-to-peer exchanges will focus on type 2 asthmatic inflammation, which includesallergic and eosinophilic asthma. The speakers will also give insight into the heterogeneity of asthma and its impact on the diagnosis of the disease. In addition, the panel will better understand the identification of biomarkers that can facilitate phenotyping and personalize the treatment of these patients.
For more information and to view the video series on MDMag.com, click here.
DO YOU WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe for free to the newsletter Global Banking & Finance Review Access exclusive reports to save time and money
By using this form, you accept the storage and processing of your data through this site. We will not spam, rent or sell your information.
All emails include an unsubscribe link. You can unsubscribe anytime. See our privacy policy.
Sure MD Magazine
MD Magazine is a comprehensive information and clinical information portal that provides physicians and other health professionals with up-to-date resources on specific specialties and diseases designed to help them provide better patient care. Readers have access to breaking news, video interviews with expert physicians, in-depth coverage of the conference, financial and practice management updates, badysis and badysis. badyzes of medical collaborators and other resources. MD Magazine is part of MJH Associates, Inc., the largest independent, full-service medical media company in the United States dedicated to delivering reliable health care information through multiple channels.
MD Magazine® Media Contacts:
Alexandra
Ventura, 609-716-7777 ext. 121
[email protected]
John Patricolo, 609-325-4630
[email protected]
Source link
